IM Cannabis (IMCC) Change in Accured Expenses (2019 - 2026)

IM Cannabis' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 135.09% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$6.1 million, a 867.35% decrease from a year earlier, with the FY2024 full-year figure at -$5.2 million, down 839.09% from the prior year.
• Change in Accured Expenses grew to -$1.4 million in Q1 2026 per IMCC's latest filing, from -$1.8 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $11.4 million in Q4 2022 and bottomed at -$6.8 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is -$345000.8 (2022), against an average of $260141.6.
• Across the five-year window, Change in Accured Expenses slumped 19571.21% in 2024 and surged 289.67% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $11.4 million in 2022, then slumped by 106.55% to -$745553.6 in 2023, then tumbled by 818.58% to -$6.8 million in 2024, then surged by 73.98% to -$1.8 million in 2025, then increased by 23.92% to -$1.4 million in 2026.
• Per Business Quant, the three latest IMCC Change in Accured Expenses figures stand at -$1.4 million (Q1 2026), -$1.8 million (Q2 2025), and $3.9 million (Q1 2025).